FROM THE EDITOR-IN-CHIEF
T cells are being rebuilt to kill cancer cells.
by William G. Nelson, MD, PhD
Targeted Chemotherapy | Drug Combo Targets Polyp Growth | FDA Acts to Curb Nicotine Use | Cloning Cancer | Putting Age in the Cancer Picture | Back to School | What’s Next?
The number of cancer survivors is growing. We must step up efforts to meet their needs.
by Elizabeth M. Jaffee, MD
YOUR CANCER GUIDE
A second opinion can provide additional information to determine the best treatment course.
by Hester Hill Schnipper
CAREGIVING WITH CONFIDENCE
Recognize the signs of a serious mental illness and get help if you need it.
by Lisa O’Leary
Janet Freeman-Daily helps put patients at the center of lung cancer research.
by Robin Meadows
People with metastatic breast cancer are demanding to be seen, counted and included in breast cancer research.
by Sue Rochman
Cancer rehabilitation can help patients before and after treatment, but it’s still not widely used.
by Cameron Walker
After decades without treatment advances, options for patients with bladder cancer are now more numerous.
by Kendall K. Morgan
Go Fish | Against the Clock
Palliative care specialist Jessica Nutik Zitter offers tips to help ensure that patients’ values guide end-of-life decisions.
by Marci A. Landsmann
A patient support expert offers guidance on how to respond to news of a friend’s cancer diagnosis.
Help with Hope delivers care packages to young people whose mother or father has received a cancer diagnosis.
by Lindsey Konkel
Tanya Waring-Hearn, Amy Rowley, Elsie Young.
A study investigates how people who have been diagnosed with cancer feel about being called survivors.
by Jen Tota McGivney
Broadening clinical trial eligibility criteria to include cancer patients who also have other health conditions could increase trial enrollment.
by Ashley P. Taylor
A study investigates whether a commonly used clinical trial endpoint, progression-free survival, can be used to predict quality of life.
by Jon Kelvey
A new vaccine is safe for cancer patients but hard to find.
by Nancy Averett
In the past few decades, most of the progress that has been made against cervical cancer has been in the areas of prevention and early detection.
The U.S. Food and Drug Administration rounded out 2018 with three oncology approvals.
What are the side effects of immune checkpoint inhibitors and how do they arise?
Bob Riter: The Bridge Builder
donate to the AACR